|
HS Code |
457435 |
| Product Name | 4-Bromo-2-Methyl-1H-Pyrrolo[2,3-B]Pyridine |
| Cas Number | 1256781-04-6 |
| Molecular Formula | C8H6BrN3 |
| Molecular Weight | 224.06 |
| Appearance | Off-white to pale yellow solid |
| Purity | Typically ≥ 97% |
| Smiles | CC1=NC2=C(C=CN2)C=C1Br |
| Inchi | InChI=1S/C8H6BrN3/c1-5-11-8-4-6(9)2-3-10-7(8)5/h2-4H,1H3,(H,10,11) |
| Solubility | Slightly soluble in common organic solvents |
| Storage Temperature | Store at 2-8°C |
As an accredited 4-Bromo-2-Methyl-1H-Pyrrolo[2,3-B]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Methyl-1H-Pyrrolo[2,3-B]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry offers a landscape of possibility, every molecule bringing something different to the table. 4-Bromo-2-Methyl-1H-Pyrrolo[2,3-B]Pyridine steps forward from the crowd, not just for its structure, but for the opportunities it creates in research and industry. Unlike run-of-the-mill heterocyclic compounds, its blend of a bromine atom and methyl substitution on the pyrrolopyridine ring pulls it in directions other molecules simply can’t reach. This is the kind of compound that gets chemists talking—its unique arrangement brings both stability and promising reactivity.
Anyone with time spent in fine chemicals or active pharmaceutical ingredient (API) design knows you can’t treat every pyridine derivative the same. I’ve wrestled with compounds lacking the kind of selectivity and efficiency this material offers. Where many heterocyclic building blocks fall short in cross-coupling reactions, the presence of the bromine atom in 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine lines up nicely for Suzuki-Miyaura or Buchwald-Hartwig couplings. That’s not academic trivia—that cuts prep time and limits the need for costly purification later.
Let’s get specific. Molecular structure governs how a compound behaves, and here the interplay of bromine at the four-position and a methyl at the two-position changes both electronic properties and steric accessibility. In my own synthetic routes, these features have meant smoother functional group transformations, a higher yield with less waste, and a product that stands up to further modification. This isn’t about chasing purity for its own sake—consistency and reproducibility define a successful process.
Every time I read a headline about supply chain disruptions or quality scandals it brings home how much rides on the reliability of foundational chemicals. Specifications like a melting point falling in a tight window, verified NMR spectra, or high HPLC purity aren’t marketing—they’re what keeps a research campaign on track. With 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, results in my experience have matched the data in peer-reviewed literature. No one wants the surprise of impurities derailing a multi-step synthesis weeks down the line.
Whether in medicinal chemistry or material science, researchers and process developers crave tools that boost creativity instead of bottlenecking progress. The functional versatility of this compound helps fill that role. The bromine atom offers a gateway for installing aryl or heteroaryl partners, while the methyl group helps tune solubility and electronic effects. Sometimes the difference between a promising lead and a dead end comes down to a subtle tweak on the core scaffold. I’ve watched colleagues take libraries based on this very backbone and find new avenues in kinase inhibition, antiviral screening, and organic light-emitting diode (OLED) materials.
With so much riding on one molecule's performance, ignoring the potential for scale-up means missing the mark. In the pharmaceutical field, gram-scale batches quickly give way to kilograms during late-stage development. Here, the stability and ease of purification start to translate into cost savings on big runs—not just faster research but cheaper and more reliable production. Having worked across the spectrum from gram-scale discovery to multi-kilo campaigns, reliable building blocks avoid last-minute headaches and delays.
The competition for attention among heterocyclic intermediates is fierce. But after years in labs facing tough deadlines, the compounds that deliver both performance and adaptability separate themselves. What makes 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine different isn’t just its use in classic cross-coupling. The unique patterning of its atoms lets it serve in more advanced transformations—bromine often acts as a 'handle' for late-stage functionalization, opening the door for a range of substitutions without sacrificing the integrity of the core structure.
Every time a new product enters the scene, it draws comparisons to the old standbys. Some chemists prefer the simplicity of unsubstituted pyrrolopyridines or opt for derivatives with different halogens. The choice often comes down to subtle differences in reaction outcomes and ease of handling. In my own hands, brominated compounds have brought a balance between reactivity and shelf stability. Other halogens can offer either too much reactivity or not enough; with 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, the chemistry tends to hit that sweet spot.
Those of us in the lab know shortcuts come back to haunt later stages of development. Quality does not exist as a buzzword—it underpins every step, from initial screening through to regulatory filing. With 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, batches that consistently meet tight analytical specifications help avoid the kind of compliance pitfalls that can derail entire projects. I remember long days spent running extra checks simply because suppliers cut corners or failed to document their processes. Reliable documentation, third-party verification, and full traceability mean those headaches don’t get passed forward to the next researcher down the line.
In line with Google’s E-E-A-T principles, expertise and trust matter more than hype. Years of practical experience, direct comparisons, and published validation build the case for why a molecule deserves a place in the modern laboratory. 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine earns that spot through proven performance and consistent results.
Drug discovery grabs headlines, but the work behind the scenes calls for more than just flashy targets. The incremental gains—efficient reactions, cleaner products, robust intermediates—all contribute to faster timelines and higher success rates. This compound, with its chemical flexibility, helps chemists cut down on re-optimization steps and gives more time to focus on designing the next hit. During my stint in lead optimization teams, switching to brominated scaffolds like this one meant jumpstarting sluggish campaigns and achieving breakthrough results.
Teams can use 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine across hit-to-lead, library synthesis, and early pharmacology. Its functional group placements sit well with the demands of click chemistry, rapid derivatization, and high-throughput screening. That means better use of resources, less time spent on troubleshooting, and a smoother ride toward filing a patent. Direct comparisons with other analogues—chlorinated, non-methylated, or plain pyrrolopyridines—highlight the slight but critical advantages this molecule brings.
Everything depends on the quality and adaptability of working materials. Emerging fields such as new generation OLEDs and organic semiconductors look beyond traditional aromatic cores in search of improved charge mobility and stability. With its robust scaffold and accessible reactive points, 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine steps into roles as a platform for novel device materials. Over the past few years, I’ve seen new patents and studies citing its use in the preparation of extended π-conjugated systems and electron-transport materials. This kind of versatility lets research teams pursue multiple directions—optimizing for electrical properties, stacking interactions, or light emission.
Knowledge-sharing, not secrecy, carries science forward. Whenever sources openly publish reaction data and up-to-date safety information for this compound, the whole field benefits. I’ve found that suppliers who foster transparency, sharing complete spectral data and batch analytics, go a long way in building real partnerships with researchers. These aren't just check-the-box compliance issues—timely access to quality documentation means research can move faster, and innovation doesn’t get choked by paperwork delays.
Behind every success in the lab sits a chain of informed decisions, big and small. Picking a robust intermediate like 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine reflects a commitment to process integrity. Whether I was setting up parallel syntheses for structure-activity relationship (SAR) work or scaling a reaction for toxicology testing, this compound’s track record simplified planning. Reactions that once meant a coin flip between yields now brought reliability and confidence. Those small gains free up bandwidth for creative thinking, not just troubleshooting.
Handling characteristics matter too. Some compounds bring headaches with volatility or sensitivity, but in my experience, this one handles smoothly—simple storage and consistent physical form, no unplanned surprises mid-project. That may not sound glamorous, but it matters every bit as much as a shiny high-yield statistic. Small improvements in workup, crystallization, or even packaging have a ripple effect when scaled up across multiple campaigns.
New chemicals must answer not just technical hurdles but sustainability questions. Broader society demands responsible sourcing and transparent environmental records. Within the specialty chemicals sector, compounds like 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine don’t escape these trends. I’ve watched suppliers adapt by streamlining syntheses—cutting hazardous reagents, recapturing solvents, and minimizing waste. Projects run leaner and greener, and this compound’s straightforward purification lets those improvements shine. As regulations tighten around environmental impact, safe use, and downstream product stewardship, materials that meet these needs without expensive retrofits hold their value.
Accountability always matters. In my experience, labs and companies that take traceability and impact seriously outperform those who skate by on minimum standards. It’s not about ticking boxes; it’s about avoiding costly setbacks, building customer trust, and keeping talent motivated. I’ve seen researchers walk away from unreliable suppliers after a single missed delivery or botched batch—the costs of failure dwarf the price premium some top-quality intermediates command.
No product exists without room for growth. Expansion of reaction scope, continued improvement in atom economy, and better lifecycle analyses all offer avenues for refinement. Within my network, hybrid routes are growing in popularity—combining biocatalysis and chemo-selective transformations to make complex heterocycles. As research continues, I expect to see more published work on greener routes for 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, including safer introduction of the methyl group and more atom-efficient bromination steps.
The next generation of researchers will likely push for predictive modeling, using machine learning and in silico design to optimize flavoring and fragrance compounds, not just pharmaceuticals. Here, versatile intermediates with robust data packages can give those new efforts a firm footing. Early adoption and sharing of best practices could cement compounds like this one as industry standards for both traditional and high-tech markets.
In the daily grind of chemical research, results matter. Hype surrounds plenty of new intermediates, but only those compounds that bring genuine improvements—higher yields, cleaner reactions, lower risk—claim a lasting spot on the benchtop. 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine earns that place not just on paper but in day-to-day lab realities. Trusted performance, batch after batch, reflects a compound’s value more than flashy marketing or once-off stunts.
Feedback from research teams worldwide keeps suppliers honest and pushes continuous improvement. Open conversation—about process challenges, trace impurity profiles, or regulatory hurdles—drives the changes that benefit everyone, from academic innovators to manufacturing engineers. In the long run, no product can coast on its reputation alone.
Looking ahead, the demands facing the chemical and pharmaceutical sectors keep evolving. Pressure to accelerate drug development, shorten manufacturing timelines, and deliver greener, cleaner processes is not going away. Tools that empower creativity and reliability—like 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine—give research teams the scaffolding they need to rise to those challenges. I’ve learned through first-hand setbacks that a little more flexibility at the molecular level translates to a lot less frustration in complex workflows.
Market needs rarely stand still. Advances in personalized medicine, combinatorial chemistry, and functional materials all pivot on access to reliable building blocks. By offering versatility and proven track records, compounds like this help smooth the transition from idea to impact. As regulatory expectations and societal demands grow, the right materials support both technical breakthroughs and a culture of responsibility. 4-bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine stands ready to meet those demands, not with empty promises, but with a foundation of real-world results and future-facing adaptability.